Robert B. Darnell, M.D., Ph.D., is the Robert and Harriet Heilbrunn Professor of Cancer Biology at Rockefeller University in New York City and the Director for Science Programs at the Center for Clinical and Translational Research for the Rockefeller University Hospital, where he is also Senior Physician. In addition, he is an Attending Neurologist at New York City’s Memorial Sloan-Kettering Cancer Center. Dr. Darnell is an investigator with the Howard Hughes Medical Institute and a leading expert in the study of paraneoplastic neurologic syndromes, a group of rare disorders triggered by an immune system response to common cancers. He pioneered the development of new methods to study RNA regulation in the brain, and his research has led to the discovery of neuron-specific systems for regulating RNA. His work has resulted in several awards, patents and Investigational New Drug applications. Dr. Darnell is an elected member of the Institute of Medicine, a fellow of the American Association for the Advancement of Science, and a former chair of the NINDS Board of Scientific Counselors.
Last Modified January 19, 2012